Pulmonary arterial hypertension (PAH) is a rare condition that's difficult to treat. The hallmarks of the disease—narrowing ...

Arquitos Capital shares its Q3 2025 investor letter highlighting a 66.8% YTD return and value-driven strategy. Read how ...

GSK plc announced plans to invest $30 billion in U.S. research and manufacturing over the next five years and entered a $500 ...

A cutting-edge procedure for those suffering from the heart condition atrial fibrillation has been successfully performed for ...

Georgia Northwestern Technical College respiratory care graduate, Jay Shedd, system director of Respiratory Therapy, Sleep ...

The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...

Key points A 68-year-old woman from rural Ontario arrived at her local emergency department with worsening palpitations. Her medical history included breast cancer treated with surgical resection and ...

EMA committee recommends approval of Insmed’s Brinsupri to treat non-cystic fibrosis bronchiectasis: Bridgewater, New Jersey Monday, October 20, 2025, 15:00 Hrs [IST] Insmed Inc ...

Today at HLTH, healthcare's #1 must-attend innovation event, 51&, a groundbreaking women's health network, officially launched with a bold mission: to create sustainable, system-wide funding for women ...

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) invests $4 million in exchange for a 30% ownership stake and joint control in RedHill's Talicia business U.S. co-commercialization ...

Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...

Researchers assessed disparities in COPD clinical trial participation based on gender, COPD severity, and geography and evaluated gender representation among researchers.